Tamiflu For All Ages: Roche’s Influenza Antiviral Cleared In Europe For Adolescents
This article was originally published in The Pink Sheet Daily
Executive Summary
European Medicines Agency recommends monitoring of potential psychiatric adverse events associated with oseltamivir but does not feel a warning is warranted.
You may also be interested in...
Tamiflu Cleared For Pediatric Flu Prevention
Roche's antiviral oseltamivir is now approved for treatment and prevention of influenza in children, adolescents and adults.
Tamiflu Cleared For Pediatric Flu Prevention
Roche's antiviral oseltamivir is now approved for treatment and prevention of influenza in children, adolescents and adults.
Tamiflu Adverse Event One Year Update Requested By Advisory Committee
Pediatric Advisory Committee agrees with FDA that neuropsychiatric events and deaths seen in pediatric patients receiving the antiviral do not represent risk signals.